EVOLUS INC. - COMMON

Evolus Announces Participation in November Investment Conferences

09 Nov 2021 07:30:00 By Nasdaq GlobeNewswire

Evolus Reports Third Quarter 2021 Results and Provides Business Update

02 Nov 2021 07:03:00 By Nasdaq GlobeNewswire

Evolus Initiates Phase II Program with “Extra Strength” Dose for Extended Duration

02 Nov 2021 07:01:00 By Nasdaq GlobeNewswire

Evolus Announces Appointment of Jessica Novak as Senior Vice President, Human Resources

01 Nov 2021 15:10:00 By Nasdaq GlobeNewswire

Evolus to Report Third Quarter 2021 Results and Provide Business Update

22 Oct 2021 08:00:00 By Nasdaq GlobeNewswire

Evolus Announces Participation in September Investment Conferences

02 Sep 2021 08:00:00 By Nasdaq GlobeNewswire

Evolus Reports Second Quarter 2021 Results and Provides Business Update

04 Aug 2021 15:05:03 By Nasdaq GlobeNewswire

Evolus to Report Second Quarter 2021 Results and Provide Business Update

22 Jul 2021 08:00:02 By Nasdaq GlobeNewswire

Evolus Announces Appointment of David K. Erickson as Vice President, Investor Relations

30 Jun 2021 08:00:00 By Nasdaq GlobeNewswire

Peer Reviewed Article Highlights Efficacy and Safety of Jeuveau® in Patients with Skin of Color

24 Jun 2021 08:00:01 By Nasdaq GlobeNewswire

Evolus Appoints Dan Stewart as Vice President and General Manager, International

19 May 2021 08:00:01 By Nasdaq GlobeNewswire

Evolus Reports First Quarter 2021 Results and Provides Business Update

12 May 2021 15:05:02 By Nasdaq GlobeNewswire

Aesthetic Surgery Journal Publishes Long Term Safety and Efficacy Data of Jeuveau® for the Treatment of Moderate to Severe Frown Lines

12 May 2021 08:00:01 By Nasdaq GlobeNewswire

Evolus to Report First Quarter 2021 Results and Provide Business Update

04 May 2021 15:05:01 By Nasdaq GlobeNewswire

Evolus to Participate in the 7th Annual Truist Securities Life Sciences Summit

29 Apr 2021 15:05:01 By Nasdaq GlobeNewswire

Evolus Announces Pricing of Public Offering of Common Stock

21 Apr 2021 21:30:50 By Nasdaq GlobeNewswire

Evolus Announces Proposed Public Offering of Common Stock

21 Apr 2021 15:01:00 By Nasdaq GlobeNewswire

Evolus Reports Fourth Quarter and Full Year 2020 Results and Provides Business Update

24 Mar 2021 15:05:00 By Nasdaq GlobeNewswire

Evolus to Report Fourth Quarter and Year End 2020 Results and Provide Business Update

23 Mar 2021 08:20:56 By Nasdaq GlobeNewswire

Evolus Strengthens Balance Sheet Through a $25.5 Million Cash Infusion and Elimination of $127.4 Million of Debt and Milestone Payments

23 Mar 2021 08:17:47 By Nasdaq GlobeNewswire